Company intelligence / Profile preview

USPlabs

Dallas, Texas, United Stateshitechpharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

USPlabs developed and marketed sports nutrition and weight-loss supplements, notably OxyElite Pro and Jack3d, which became controversial due to links to serious adverse events including acute hepatitis, liver failure, and death. Multiple products were recalled and the company ceased operations following criminal convictions for misbranding and fraud[2][3][5][6].

Therapeutic areas: Metabolic DisordersEndocrinologyMen's Health
Modalities: Small molecule
Industry: Food & Nutrition

Drug pipeline

4 assets

Jack3d

Commercial

Indications: Exercise performance

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on USPlabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on USPlabs.

Explore the full profile